US Stock MarketDetailed Quotes
HALO Halozyme Therapeutics
- 45.700
- -0.060-0.13%
Close Nov 21 16:00 ET
- 46.150
- +0.450+0.98%
Post 20:01 ET
5.81BMarket Cap15.13P/E (TTM)
46.115High44.800Low1.30MVolume45.850Open45.760Pre Close59.01MTurnover1.03%Turnover Ratio21.76P/E (Static)127.23MShares65.53352wk High12.84P/B5.75BFloat Cap33.15052wk Low--Dividend TTM125.89MShs Float65.533Historical High--Div YieldTTM2.87%Amplitude1.410Historical Low45.465Avg Price1Lot Size
Halozyme Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -12.87%115.38M | -16.53%55.79M | 48.83%129.43M | 61.83%388.57M | 24.14%102.35M | 90.15%132.41M | 66.17%66.84M | 81.94%86.96M | -19.81%240.11M | -0.08%82.45M |
| Net income from continuing operations | 67.42%137.01M | 24.74%93.25M | 93.92%76.82M | 39.31%281.59M | 47.98%85.39M | 32.78%81.84M | 229.53%74.75M | -34.09%39.62M | -49.81%202.13M | -13.58%57.7M |
| Operating gains losses | --0 | --1.68M | ---7K | -67.08%611K | 91.84%94K | --0 | ---- | ---- | --1.86M | --49K |
| Depreciation and amortization | -11.78%20.36M | -1.44%20.33M | -1.23%20.21M | 70.94%84.86M | 190.88%20.69M | -20.97%23.08M | 64.42%20.63M | 2,529.43%20.46M | 1,556.36%49.64M | 820.31%7.11M |
| Deferred tax | -96.99%292K | 23.76%14.24M | -66.68%1.29M | -13.75%34.51M | -35.79%9.42M | -62.25%9.7M | 186.53%11.51M | -70.03%3.87M | 125.74%40.01M | 213.30%14.68M |
| Other non cash items | 118.03%2.2M | 842.66%2.12M | -4.87%2.05M | -166.78%-4.63M | 777.43%5.68M | -313.02%-12.17M | -203.25%-286K | 645.67%2.16M | -69.01%6.93M | 125.44%647K |
| Change In working capital | -344.22%-53.94M | -69.70%-82.26M | 56.04%21.56M | 55.01%-38.67M | -413.80%-26.1M | 137.06%22.09M | -566.37%-48.48M | 143.62%13.81M | -2,399.38%-85.95M | -123.33%-5.08M |
| -Change in receivables | -346.84%-71.22M | 63.84%-18.62M | 5.86%38.31M | 96.02%-3.34M | -117.73%-16.89M | 165.67%28.85M | -444.07%-51.5M | 258.81%36.19M | -1,342.65%-83.94M | -136.71%-7.76M |
| -Change in inventory | -45.51%1.98M | 13.48%-21.4M | -454.94%-40.23M | -53.79%-26.88M | 149.88%1.47M | 165.94%3.63M | -61.44%-24.74M | -215.12%-7.25M | -337.16%-17.48M | -232.72%-2.95M |
| -Change in prepaid assets | 555.42%38.48M | -994.47%-43.54M | -46.01%4.8M | 145.21%4.1M | -122.68%-1.2M | -67.66%-8.45M | 3,323.84%4.87M | 196.87%8.88M | 21.56%-9.06M | 205.02%5.3M |
| -Change in payables and accrued expense | -1,088.21%-23.18M | -94.30%1.3M | 177.83%18.69M | -151.14%-12.55M | -3,007.67%-9.48M | 61.85%-1.95M | -35.22%22.89M | -299.43%-24.01M | 2,002.40%24.54M | -90.61%326K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -12.87%115.38M | -16.53%55.79M | 48.83%129.43M | 61.83%388.57M | 24.14%102.35M | 90.15%132.41M | 66.17%66.84M | 81.94%86.96M | -19.81%240.11M | -0.08%82.45M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -100.70%-167.48M | -176.44%-42.04M | -37.43%-82.68M | 80.10%-96.91M | -374.86%-8.29M | -8,178.77%-83.45M | 112.64%54.99M | -22.02%-60.16M | -19.87%-487.01M | 99.42%-1.75M |
| Net PPE purchase and sale | 48.47%-1.52M | -259.09%-2.58M | 68.84%-3.55M | -217.96%-15.29M | -10.75%-2.6M | -192.06%-2.94M | 267.67%1.62M | -2,221.84%-11.38M | -230.13%-4.81M | -1,383.54%-2.34M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---999.12M | --0 |
| Net investment purchase and sale | -106.15%-165.97M | -173.93%-39.46M | -62.21%-79.14M | -116.62%-81.62M | 39.33%-5.7M | ---80.51M | -90.28%53.37M | 0.06%-48.79M | 221.26%490.92M | 96.86%-9.39M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --26.01M | --9.99M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -100.70%-167.48M | -176.44%-42.04M | -37.43%-82.68M | 80.10%-96.91M | -374.86%-8.29M | -8,178.77%-83.45M | 112.64%54.99M | -22.02%-60.16M | -19.87%-487.01M | 99.42%-1.75M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 352.60%18.56M | 287.65%9.48M | 99.70%-489K | -212.59%-407.99M | -4,048.81%-249.92M | 133.07%4.1M | -99.33%2.45M | -26,480.45%-164.61M | 365.38%362.37M | 104.06%6.33M |
| Net issuance payments of debt | --0 | --0 | --0 | -102.16%-13.48M | --0 | --0 | --0 | ---13.48M | 50.20%624.55M | --0 |
| Net common stock issuance | --0 | --0 | --0 | -101.19%-402.38M | -25,229,900.00%-252.3M | --0 | --0 | ---150.08M | 42.87%-200M | 100.00%-1K |
| Proceeds from stock option exercised by employees | 352.60%18.56M | 287.65%9.48M | 53.34%-489K | -43.92%7.88M | -65.85%2.38M | 55.58%4.1M | -35.99%2.45M | -267.95%-1.05M | 12.08%14.05M | 61.69%6.97M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -17,877.36%-76.22M | ---639K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 352.60%18.56M | 287.65%9.48M | 99.70%-489K | -212.59%-407.99M | -4,048.81%-249.92M | 133.07%4.1M | -99.33%2.45M | -26,480.45%-164.61M | 365.38%362.37M | 104.06%6.33M |
| Net cash flow | ||||||||||
| Beginning cash position | -15.06%187.86M | 69.92%164.63M | -49.56%118.37M | 96.86%234.7M | 85.72%274.23M | 141.89%221.17M | -18.13%96.88M | 96.86%234.7M | -19.56%119.22M | -70.00%147.66M |
| Current changes in cash | -163.22%-33.55M | -81.30%23.24M | 133.57%46.26M | -200.74%-116.33M | -279.07%-155.86M | -5.63%53.06M | 561.96%124.28M | -15,489.59%-137.81M | 498.41%115.48M | 123.34%87.04M |
| End cash Position | -43.73%154.32M | -15.06%187.86M | 69.92%164.63M | -49.56%118.37M | -49.56%118.37M | 85.72%274.23M | 141.89%221.17M | -18.13%96.88M | 96.86%234.7M | 96.86%234.7M |
| Free cash flow | -12.06%113.86M | -22.28%53.21M | 66.54%125.88M | 58.64%373.28M | 24.53%99.76M | 88.65%129.47M | 74.40%68.47M | 59.78%75.59M | -21.04%235.3M | -2.73%80.11M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data